dr. david hyman, an oncologist with memorial sloan kettering cancer center.bout cancer, as we talk about hope let's just kind of clarify, what is the current way we treat cancers and what are some of these new studies showing? >>. >> the historic ways that we've always treated cancers is treating them based on the organ they come from. so treating patients with breast cancer or colon cancer or lung cancer eye dent-- eye dentically am what these are asking is whether we can target specific mutations which are mystics in the genes that arise in tumors and treat them the same even if they come from different organs. so we recognize that there are certain mutations that we find-- we find across multiple disease types. and so one question is can we really start to think about these diseases as diseases harboring mutation a or b rather than lung cancers or colon cancers. >> and so how effective are these drugs when they target a specific mutation instead of a specific region of the body that the cancer is coming from? >> they can be very dramatically effective in w